Broadfin Healthcare Master Fund Ltd Insider Trading for November 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Broadfin Healthcare Master Fund Ltd.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Broadfin Healthcare Master Fund Ltd for November 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.61 | 100 | 961 | 2,705,262 | 2.7 M to 2.7 M (0.00 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.55 | 100,000 | 955,000 | 2,705,362 | 2.8 M to 2.7 M (-3.56 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.55 | 50,000 | 477,500 | 2,805,362 | 2.9 M to 2.8 M (-1.75 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.62 | 5,000 | 48,100 | 2,855,362 | 2.9 M to 2.9 M (-0.17 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.69 | 500 | 4,845 | 2,860,362 | 2.9 M to 2.9 M (-0.02 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.63 | 6,322 | 60,881 | 2,860,862 | 2.9 M to 2.9 M (-0.22 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.71 | 100 | 971 | 2,867,184 | 2.9 M to 2.9 M (0.00 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.71 | 6,381 | 61,960 | 2,867,284 | 2.9 M to 2.9 M (-0.22 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.66 | 3,764 | 36,360 | 2,873,665 | 2.9 M to 2.9 M (-0.13 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.68 | 700 | 6,776 | 2,877,429 | 2.9 M to 2.9 M (-0.02 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.68 | 2,200 | 21,296 | 2,878,129 | 2.9 M to 2.9 M (-0.08 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.56 | 21,619 | 206,678 | 2,880,329 | 2.9 M to 2.9 M (-0.74 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.68 | 1,500 | 14,520 | 2,901,948 | 2.9 M to 2.9 M (-0.05 %) |
| Nov 30 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.71 | 24,430 | 237,215 | 2,903,448 | 2.9 M to 2.9 M (-0.83 %) |
| Nov 24 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.37 | 5,900 | 55,283 | 2,927,878 | 2.9 M to 2.9 M (-0.20 %) |
| Nov 24 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.48 | 1,450 | 13,746 | 2,933,778 | 2.9 M to 2.9 M (-0.05 %) |
| Nov 24 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.39 | 5,800 | 54,462 | 2,935,228 | 2.9 M to 2.9 M (-0.20 %) |
| Nov 24 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.31 | 2,051 | 19,095 | 2,941,028 | 2.9 M to 2.9 M (-0.07 %) |
| Nov 24 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.32 | 2,913 | 27,149 | 2,943,079 | 2.9 M to 2.9 M (-0.10 %) |
| Nov 24 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.36 | 3,088 | 28,904 | 2,945,992 | 2.9 M to 2.9 M (-0.10 %) |
| Nov 24 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.37 | 48,566 | 455,063 | 2,949,080 | 3 M to 2.9 M (-1.62 %) |
| Nov 24 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.37 | 2,440 | 22,863 | 2,997,646 | 3 M to 3 M (-0.08 %) |
| Nov 24 2017 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.50 | 100,000 | 950,000 | 3,000,086 | 3.1 M to 3 M (-3.23 %) |
| Nov 20 2017 | MYG | Mirati Therapeutic ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 18.05 | 60,000 | 1,083,000 | 2,728,601 | 2.8 M to 2.7 M (-2.15 %) |
| Nov 17 2017 | CORI | Corium Internation ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 10.95 | 25,000 | 273,750 | 3,568,626 | 3.6 M to 3.6 M (-0.70 %) |
| Nov 17 2017 | CORI | Corium Internation ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 10.96 | 9,255 | 101,435 | 3,593,626 | 3.6 M to 3.6 M (-0.26 %) |
| Nov 17 2017 | CORI | Corium Internation ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 10.95 | 100,000 | 1,095,000 | 3,602,881 | 3.7 M to 3.6 M (-2.70 %) |
| Nov 17 2017 | CORI | Corium Internation ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 11.01 | 65,345 | 719,448 | 3,702,881 | 3.8 M to 3.7 M (-1.73 %) |
| Nov 17 2017 | CORI | Corium Internation ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 10.97 | 400 | 4,388 | 3,768,226 | 3.8 M to 3.8 M (-0.01 %) |
| Nov 17 2017 | CORI | Corium Internation ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 10.88 | 25,000 | 272,000 | 3,768,626 | 3.8 M to 3.8 M (-0.66 %) |
| Nov 17 2017 | CORI | Corium Internation ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 10.85 | 25,000 | 271,250 | 3,793,626 | 3.8 M to 3.8 M (-0.65 %) |
| Nov 17 2017 | CORI | Corium Internation ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 10.97 | 250,000 | 2,742,500 | 3,818,626 | 4.1 M to 3.8 M (-6.14 %) |
| Nov 03 2017 | CORI | Corium Internation ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 11.05 | 150,000 | 1,657,500 | 4,068,626 | 4.2 M to 4.1 M (-3.56 %) |